SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001551986-23-000028
Filing Date
2023-04-27
Accepted
2023-04-27 08:17:46
Documents
14
Period of Report
2023-04-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nmtr-20230426.htm   iXBRL 8-K 50002
2 EX-10.1 ex-101forbearanceagmt423.htm EX-10.1 68628
  Complete submission text file 0001551986-23-000028.txt   300789

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nmtr-20230426.xsd EX-101.SCH 2141
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nmtr-20230426_def.xml EX-101.DEF 6756
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nmtr-20230426_lab.xml EX-101.LAB 29753
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nmtr-20230426_pre.xml EX-101.PRE 15762
8 EXTRACTED XBRL INSTANCE DOCUMENT nmtr-20230426_htm.xml XML 13971
Mailing Address 4509 CREEDMOOR ROAD SUITE 201 RALEIGH NC 27612
Business Address 4509 CREEDMOOR ROAD SUITE 201 RALEIGH NC 27612 919-275-1933
9 METERS BIOPHARMA, INC. (Filer) CIK: 0001551986 (see all company filings)

IRS No.: 273948465 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37797 | Film No.: 23852067
SIC: 2834 Pharmaceutical Preparations